About the Company

法伯新天正是一家专注于核医学领域的创新型药物研发公司,擅长为科学家自主创新成果转化提供整体解决方案。公司成立于2016年1月28日,在公司发展历程当中,形成了三步走的战略。*阶段,法伯新天形成了相对完整的服务链条,能够提供较为完善的新药转化整体解决方案,成为了专注于核医学领域的特色CRO;第二阶段,通过合理让渡利润等多种方式,逐步获取部分服务项目的产品权益;第三阶段,通过跟科学家的早期互动,充分利用国内学术及研发资源,完成了自主研发平台的搭建及新产品储备。法伯新天也逐渐成长为专注分子影像学及核医学的新药研发企业。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 3,000万(元)
Legal Representative: 汪纯
Date Established:
Credit Code: 91110105MA01HC2572
Registered Address: 北京市大兴区榆顺路12号D座3652号中国(北京)自由贸易试验区高端产业片区

People who follow this company also follow

Competitors (Similar Companies)

医药 抗肿瘤药 化学合成药 肿瘤药物
“Health for Humanity, Creating a Better Future Together”
医药 生物医药 原料药 化学原料药
医药 医药中间体 新药研发 仿制药
“A renowned enterprise in China's liver disease and anti-tumor fields”
制药/药业 软膏剂 生物制品 乳膏剂
“Providing solutions for personalized treatment and health management”
“一家专业从事新药研发的高新技术企业”
医药 新药研发 微波合成 合成仪
医药 生物医药 生物科技/生物工程 纳米微球
制药/药业 医药 生产 医药分析
“To become an enterprise with value of existence, serving human health ”
“是一家集药品研发、化学及生化药品中间体合成、分析检测及原料药生产于一体的高科技医药研发生产企业”
“A technology-driven international pharmaceutical enterprise”
制药/药业 生物制药 医药中间体 原料药

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates